Open Access
Issue
BIO Web Conf.
Volume 233, 2026
9th International Conference on Advances in Biosciences and Biotechnology: Emerging Innovations in Biomedical and Bioengineering Sciences (ICABB 2026)
Article Number 04003
Number of page(s) 6
Section Multi-Omics, Green Chemistry and Artificial Advancements in Biotechnology
DOI https://doi.org/10.1051/bioconf/202623304003
Published online 23 April 2026
  • T. K. Suvvari, “The persistent threat of tuberculosis - Why ending TB remains elusive?,” J. Clin. Tuberc. Other Mycobact. Dis., vol. 38, p. 100510, Feb. 2025, doi: 10.1016/j.jctube.2025.100510. [Google Scholar]
  • A. Egorova, E. G. Salina, and V. Makarov, “Targeting Non-Replicating Mycobacterium tuberculosis and Latent Infection: Alternatives and Perspectives (Mini-Review),” Int. J. Mol. Sci., vol. 22, no. 24, p. 13317, Dec. 2021, doi: 10.3390/ijms222413317. [Google Scholar]
  • J. E. Griffin et al., “Cholesterol Catabolism by Mycobacterium tuberculosis Requires Transcriptional and Metabolic Adaptations,” Chem. Biol., vol. 19, no. 2, pp. 218–227, Feb. 2012, doi: 10.1016/j.chembiol.2011.12.016. [Google Scholar]
  • M. Antil and V. Gupta, “Lessons Learnt and the Way Forward for Drug Development Against Isocitrate Lyase from Mycobacterium tuberculosis,” Protein Pept. Lett., vol. 29, no. 12, pp. 1031–1041, Dec. 2022, doi: 10.2174/0929866529666221006121831. [Google Scholar]
  • V. Sharma et al., “Structure of isocitrate lyase, a persistence factor of Mycobacterium tuberculosis,” Nat. Struct. Biol., vol. 7, no. 8, pp. 663–668, Aug. 2000, doi: 10.1038/77964. [Google Scholar]
  • R. P. Bhusal et al., “Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2,” Nat. Commun., vol. 10, no. 1, p. 4639, Oct. 2019, doi: 10.1038/s41467-019-12614-7. [Google Scholar]
  • P. Bhatter, P. Gupta, P. Daswani, P. Tetali, and T. Birdi, “Antimycobacterial Efficacy of Andrographis paniculata Leaf Extracts Under Intracellular and Hypoxic Conditions,” J. Evid. Based. Complementary Altern. Med., vol. 20, no. 1, pp. 3–8, Jan. 2015, doi: 10.1177/2156587214553303. [Google Scholar]
  • K. Mohanraj et al., “IMPPAT: A curated database of Indian Medicinal Plants, Phytochemistry And Therapeutics,” Sci. Rep., vol. 8, no. 1, p. 4329, Mar. 2018, doi: 10.1038/s41598-018-22631-z. [Google Scholar]
  • J. Eberhardt, D. Santos-Martins, A. F. Tillack, and S. Forli, “AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings,” J. Chem. Inf. Model., vol. 61, no. 8, pp. 38913898, Aug. 2021, doi: 10.1021/acs.jcim.1c00203. [Google Scholar]
  • A. Daina, O. Michielin, and V. Zoete, “SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules,” Sci. Rep., vol. 7, no. 1, p. 42717, Mar. 2017, doi: 10.1038/srep42717. [Google Scholar]
  • P. Banerjee, E. Kemmler, M. Dunkel, and R. Preissner, “ProTox 3.0: a webserver for the prediction of toxicity of chemicals,” Nucleic Acids Res., vol. 52, no. W1, pp. W513-W520, Jul. 2024, doi: 10.1093/nar/gkae303. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.